- Report
- February 2024
Belarus
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Bangladesh
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Bahrain
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Austria
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Australia
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Argentina
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Albania
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
United States
From €3447EUR$3,850USD£2,936GBP
- Report
- February 2024
United Kingdom
From €3133EUR$3,500USD£2,669GBP
- Report
- February 2024
Spain
From €3133EUR$3,500USD£2,669GBP
- Report
- February 2024
Japan
From €3133EUR$3,500USD£2,669GBP
- Report
- February 2024
Italy
From €3133EUR$3,500USD£2,669GBP
- Report
- February 2024
Serbia
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Russia
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Romania
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Qatar
From €2551EUR$2,850USD£2,173GBP
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Portugal
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Poland
From €2551EUR$2,850USD£2,173GBP
- Report
- February 2024
Philippines
From €2551EUR$2,850USD£2,173GBP

Immunofixation is a type of in vitro diagnostics (IVD) used to identify and quantify monoclonal immunoglobulins and light chains in serum and urine. It is a two-step process that involves the use of antibodies to separate and identify the components of a sample. The first step involves the use of a polyclonal antibody to separate the sample into its component parts. The second step involves the use of a monoclonal antibody to identify the components of the sample. Immunofixation is used to diagnose and monitor a variety of conditions, including multiple myeloma, Waldenström's macroglobulinemia, and amyloidosis.
The Immunofixation market is a rapidly growing segment of the IVD industry. It is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the need for accurate and timely diagnosis. Companies in the Immunofixation market include Abbott, Bio-Rad Laboratories, Siemens Healthineers, Ortho Clinical Diagnostics, and Thermo Fisher Scientific. Show Less Read more